MTOR and breast cancer: Upregulation of ketone body metabolism and α-ketoglutarate, both key sensors of mitochondrial perturbations that involve the mTOR pathway, provides a rationale to suggest that the partial suppression of the mitochondrial electron transport chain [38,39] by adding metformin to an established therapeutic regimen leads to a systemic catabolic response mimicking fasting in breast cancer patients.